LEKESHIA SMITH: Open Payments
NPI 1366074569 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 5 payments from 4 companies in 2025. Trend: 2023 $524 · 2024 $770 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $245 |
| Vifor Pharma, Inc. | 1 | $132 |
| Mallinckrodt Hospital Products Inc. | 1 | $122 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: Veltassa, Ozempic, TERLIVAZ, Wegovy, BENLYSTA.
Industry payments across MO — which companies pay providers there.
